Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Its been linked to an increased risk of heart disease, type 2 diabetes, and other health conditions
Studies that recruit participants in China are also important for investigating the efficacy of GLP-1 drugs in Asian populations, which could reveal differences not observed in studies from Europe or the United States
Industry forecasts project a compound annual growth rate (CAGR) of 12.4% from 2024 to 2030 , with the market size expected to exceed $18.7 billion by 2030
The transition from Phase 2 to Phase 3 also involved refinement of the dose-escalation schedule
Medicare and Medicaid generally exclude weight loss medications unless the patient also has obesity-related conditions like diabetes or hypertension
